EF Hutton analyst Chip Moore maintains Flow Beverage (TSX:FLOW) with a Buy and lowers the price target from C$3 to C$2.5.
Why Sonnet BioTherapeutics (SONN) Stock Is Getting Hammered
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 27.6% to $1.31 Wednesday morning after the company announced the pricing of a public offering involving 2,843,750 shares of common stock or pre-funded warrants, along with investor warrants allowing the purchase
